THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle
Due to more robust demand for newer treatments and a less-than-expected decline in sales of its popular arthritis medication Humira, AbbVie (ABBV.N) increased its...
Notice:
The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to
our Privacy Policy and our Cookie Policy.